Building Regulatory Agility for Adequate Access to Quality SARS-CoV-2 Test Kits During the Global Pandemic

Building Regulatory Agility for Adequate Access to Quality SARS-CoV-2 Test Kits During the Global Pandemic

The discovery of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) at the end of 2019 has placed an unprecedented strain on our global healthcare systems, economies, and individual livelihood. In the absence of a vaccine, safe and reliable testing is critical for accurate tracking of cases, timely contact tracing in the community, and isolation of infected individuals. The speed and volume of such innovations require the dedication of immense regulatory resources that no single country can or should manage alone. Thus, it is apt timing for governments to examine whether their emergency regulatory mechanisms are truly agile, and consider what can be learnt from the regulatory experiences of other countries.

Download the paper here (English Version)

Download the paper here (Chinese Version)

Download the paper here (Vietnamese Version)

Share This Post
Share on facebook
Share on linkedin
Share on twitter
Share on email

Keep up with our Online Medtech Events in the midst of Covid-19

View our full listing of events and join us.